Hoffman Robert E.
SEC insider (Form 3/4/5 filer). CIK 0001166288. Chief Executive Officer at CytoDyn Inc. (CYDY) and 3 other issuers. 11 reported Form 4/5 transactions since Sep 2024; latest on Oct 20, 2026. Located in VANCOUVER, WA.
Companies Hoffman Robert E. has filed insider reports for
- CytoDyn Inc. (CYDY): Officer, Chief Executive Officer
- Esperion Therapeutics, Inc. (ESPR): Director
- FibroBiologics, Inc. (FBLG): Director
- TuHURA Biosciences, Inc./NV (HURA): Director
Hoffman Robert E.
CIK: 0001166288
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (11 total)
- Oct 20, 2026CYDY
CytoDyn Inc.
AwardDirectNon-qualified stock option (right to buy)
2.5M shares- - Jul 13, 2026ESPR
Esperion Therapeutics, Inc.
DispositionDirect85.2K shares- - Jun 23, 2026FBLG
FibroBiologics, Inc.
AwardDirectStock Option (Right to Buy)
30.8K shares- - May 28, 2026ESPR
Esperion Therapeutics, Inc.
AwardDirect79.9K shares- - Mar 20, 2026CYDY
CytoDyn Inc.
AwardDirectNon-qualified stock option (right to buy)
4.9M shares- - Feb 12, 2026HURA
TuHURA Biosciences, Inc./NV
AwardDirectOptions (Right to Buy)
156.2K shares- - Jun 12, 2025FBLG
FibroBiologics, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - May 29, 2025ESPR
Esperion Therapeutics, Inc.
AwardDirect5.3K shares- - May 15, 2025CYDY
CytoDyn Inc.
AwardDirectNon-qualified stock option (right to buy)
1M shares- - Apr 1, 2025ESPR
Esperion Therapeutics, Inc.
AwardDirectStock Option (right to buy)
40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 20, 2026 |  CYDY CytoDyn Inc. | Award Non-qualified stock option (right to buy) | 2,500,000 | - | - | Direct |
| Jul 13, 2026 |  ESPR Esperion Therapeutics, Inc. | Disposition | 85,153 | - | $0 | Direct |
| Jun 23, 2026 |  FBLG FibroBiologics, Inc. | Award Stock Option (Right to Buy) | 30,803 | - | - | Direct |
| May 28, 2026 | ESPR Esperion Therapeutics, Inc. | Award | 79,873 | - | $0 | Direct |
| Mar 20, 2026 | CYDY CytoDyn Inc. | Award Non-qualified stock option (right to buy) | 4,874,691 | - | - | Direct |
| Feb 12, 2026 |  HURA TuHURA Biosciences, Inc./NV | Award Options (Right to Buy) | 156,240 | - | - | Direct |
| Jun 12, 2025 | FBLG FibroBiologics, Inc. | Award Stock Option (Right to Buy) | 22,000 | - | - | Direct |
| May 29, 2025 | ESPR Esperion Therapeutics, Inc. | Award | 5,280 | - | - | Direct |
| May 15, 2025 | CYDY CytoDyn Inc. | Award Non-qualified stock option (right to buy) | 1,000,000 | - | - | Direct |
| Apr 1, 2025 | ESPR Esperion Therapeutics, Inc. | Award Stock Option (right to buy) | 40,000 | - | - | Direct |
1-10 of 11 transactions